메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

전체기사

FXTRADING.com、Amit Kaushik氏を最高マーケティング責任者に任命グローバル成長とブランド拡大を加速

シドニー、2025年12月9日 --グローバルなマルチアセットブローカーであるFXTRADING.comは、Amit Kaushik氏を新たに最高マーケティング責任者（CMO）に任命しました。これは、同社の国際的成長とリーダーシップの進化における新たな節目となります。 Amit氏は、Meta および Airwallexでの上級役職を含む、グローバルフィンテックおよびテクノロジーブランドでの 15 年を超える経験を持って FXTRADING.com に入社し、そこで地域間マーケティング、製品ストーリーテリング、デジタル成長イニシアチブを主導しました。FXTRADING.comが新しいウェブサイトと統合型オールインワントレーディングポータルを立ち上げた後、グローバル展開を拡大し社内技術力を強化しているタイミングでの任命となります。 CMOとして、Amit 氏はFXTRADING.comのグローバルマーケティング戦略を統括し、ブランド拡大、デジタルイノベーション、APAC、MENA、ヨーロッパの主要市場でのスケーラブルな成長に注力します。同氏は、製品および技術チームと緊密に連携し、FXTRADING.comを信頼性が高く、パフォーマンス重視でテクノロジー主導のブローカーとしての地位を高める役割を担います。 F
- 황정호 기자
- 2025-12-09 11:00
FXTRADING.com, 아밋 카우식 신임 최고마케팅책임자(CMO)로 임명...글로벌 성장 및 브랜드 확장 가속화

시드니 2025년 12월 9일 -- 글로벌 멀티애셋 브로커 FXTRADING.com이 아밋 카우식(Amit Kaushik)을 신임 최고마케팅책임자(CMO)로 임명했다. 이는 회사의 글로벌 성장과 리더십 체계를 강화하는 또 하나의 이정표다. 이번에 FXTRADING.com에 합류한 아밋 카우식 신임 CMO은 메타(Meta)와 에어월렉스(Airwallex) 등 글로벌 핀테크 및 기술 기업에서 15년 이상 경력을 쌓았으며, 이전 직책에서는 지역 간 마케팅, 제품 스토리텔링, 디지털 성장 이니셔티브를 주도했다. 이번 임명은 FXTRADING.com이 새 웹사이트와 통합형 '올인원 트레이딩 포털(All-in-One Trading Portal)'을 출시한 이후 글로벌 입지를 확대하고 내부 기술 역량을 강화하는 시점에 이뤄졌다. CMO로서 아밋은 FXTRADING.com의 글로벌 마케팅 전략을 총괄하며, 아시아 태평양(APAC), 중동 및 북아프리카(MENA), 유럽의 주요 시장에서 브랜드 확장, 디지털 혁신, 확장 가능한 성장에 중점을 둘 예정이다. 그는 제품 및 기술팀과 긴밀히 협력해 신뢰할 수 있는 성과 중심•
- 황정호 기자
- 2025-12-09 11:00
Greenyn Biotechnology Launches Insumate® mcIRBP-19 Bitter Melon Peptide, Targeting the Billion-Dollar Health Supplement Market

TAICHUNG, Dec. 9, 2025 -- Backed by New Medical Association Certification, Insumate® Becomes the Only Bitter Melon Peptide Globally Recognized by FDA-NDI, SNQ, and the Taiwan Complementary Medicine Society (TCMS). As global demand for scientifically validated metabolic health ingredients continues to rise, Greenyn Biotechnology Co., Ltd., a publicly listed biotechnology company in Taiwan, announced today that its flagship ingredient Insumate® mcIRBP-19 Bitter Melon Peptide has been awarded the "Excellent Product Quality Certification" by the Taiwan Complementary Medic
- 김갑성 기자
- 2025-12-09 10:30
HKEX Expands Index Business with Launch of HKEX Tech 100 Index

[ 메디채널 황정호 기자 ] New index tracks 100 companies listed in Hong Kong across six major technology-focused themes HKEX's first Hong Kong equity index, marking a significant milestone in Group's index and data business development HKEX enters licensing agreement with E Fund Management to issue an ETF in Chinese Mainland market HONG KONG, Dec. 9, 2025 -- Hong Kong Exchanges and Clearing Limited (HKEX) is pleased to announce a major expansion of its index portfolio with the launch of the HKEX Tech 100 Index (HKEX Tech 100), the Group's first Hong Kong equity index that underscores its
- 황정호 기자
- 2025-12-09 10:30
Ascentium and Standard Chartered Announce Strategic Partnership to Simplify Cross-Border Growth

HONG KONG, Dec. 9, 2025 -- Ascentium has partnered with Standard Chartered to make cross-border expansion simpler and faster for businesses across Asia-Pacific (APAC). Formalised through a Memorandum of Understanding, the collaboration is designed to empower clients to seize opportunities in the region with practical, clear solutions. Launching in Hong Kong with a fast-track banking service for Ascentium clients, the partnership helps businesses open accounts quickly and begin operations without unnecessary delays. While Hong Kong is the starting point, both organisations plan to exten
- 황정호 기자
- 2025-12-09 10:10
Significant Improvement in Quality of Life Reported in Updated HARMONi-6 Data for Ivonescimab at ESMO Asia

HONG KONG, Dec. 9, 2025 -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that at the 2025 ESMO Asia Congress, updated results from the pivotal Phase III HARMONi-6 study (AK112-306) were shared in an oral presentation by Professor Shun Lu from Shanghai Chest Hospital. The study evaluates ivonescimab (a first-in-class PD-1/VEGF bispecific antibody) combined with chemotherapy versus tislelizumab combined with chemotherapy in first-line treatment for advanced squamous non-small cell lung cancer (sq-NSCLC). Beyond the previously reported efficacy data presen
- 김갑성 기자
- 2025-12-09 10:02
Aspire launches fast, low-cost international payments in Hong Kong, expanding partnership with Wise Platform

Powered by local rails, the partnership enables fast, low-cost transfers in more than 40 currencies. HONG KONG, Dec. 9, 2025 -- Aspire, the leading all-in-one ﬁnance platform for modern businesses, is taking its mission to build a truly connected ﬁnancial ecosystem further with the launch of fast, low-cost international payments in Hong Kong. Powered by Wise Platform, Wise's global payment infrastructure for banks and enterprises, the new integration enables customers to send money in more than 40 currencies, including to countries like Singapore, the United States, Australia,
- 황정호 기자
- 2025-12-09 10:00
Therme Group acquires full Thermengruppe Josef Wund portfolio through Therme Horizon, integrating all four Wund-origin destinations into its global platform

MUNICH, Dec. 9, 2025 -- Therme Group, a leading developer, owner and operator shaping the future of wellbeing infrastructure, today announced the acquisition of three thermal wellbeing destinations — Euskirchen, Sinsheim, and Titisee-Neustadt — from the Josef Wund Foundation. The transaction is subject to approval by the German Federal Cartel Office. Completed through Therme Horizon, Therme Group's joint venture with CVC Capital Partners, the acquisition brings three additional world-class destinations into the Therme ecosystem. Together with the 2024 acquisition of Therme Erdi
- 김갑성 기자
- 2025-12-09 09:00
CGTN: In the wake of tragedy, Hong Kong comes together to rebuild

BEIJING, Dec. 9, 2025 -- CGTN published an article on the post-disaster rescue and reconstruction efforts following a devastating fire in Tai Po in the Hong Kong Special Administrative Region (HKSAR), highlighting the collective efforts by the central government and the HKSAR government, Hong Kong residents, volunteers from the mainland, and different sectors of society. At Wang Fuk Court in Tai Po, residents have quietly returned to homes they'll never be able to live in again – some for the first time since the devastating fire on November 26. Many came only to retrieve what little t
- 김갑성 기자
- 2025-12-09 08:54
Inheritance + Innovation + Development: The "Co-development" Path of Hakka Medicine and Traditional Chinese Medicine

HONG KONG, Dec. 9, 2025 -- From November 23 to 25, the Seventh World Hakka Entrepreneurs Convention was held in Meizhou, Guangdong. The conference, with the theme of "Gather Global Hakka Entrepreneurs • Facilitate High-Quality Development," upheld the principles of "openness, innovation, cooperation, and mutual benefit," and explored new opportunities for the development of Hakka culture and industrial development. At this grand, globally watched event, Guangdong Jiaying Pharmaceutical Co., Ltd. showcased its star products, including "Shuangliao Houfeng San" (Dou
- 김갑성 기자
- 2025-12-09 08:00

이전

81 82 83 84 85 86 87 88 89 90

많이 본 기사

최근기사

2026-01-12_MON

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2026년 01월 12일 13시 40분